Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

4:05 PM ET Form 4
Insider Buying American Homes 4 Rent AMH

American Homes 4 Rent Insider Jack E. Corrigan Buys $194K of Stock

Jack E. Corrigan bought 9,000 shares of American Homes 4 Rent at $21.47 to $21.60 a share (average $21.51) in 4 transactions, worth $194K in total between Sep 10, 2026 and Sep 11, 2026. Shares held after the trade: 25,000 (+19.0%).

Value
$194K
Shares
9,000
Average price
$21.51
Holding change
+19.0%
Trade date
Sep 10, 2026 to Sep 11, 2026
4:05 PM ET 8-K
M&A Deal CPI Card Group Inc. PMTS

CPI Card Group M&A Deal with Tricor Pacific Capital Partners

CPI Card Group Inc. announced the closing of a secondary public offering of 2,687,921 shares of common stock by selling stockholders Tricor Pacific Capital Partners. The offering included the full exercise of the underwriters' option to purchase additional shares, and the company received zero proceeds from the sale as it was entirely a resale of shares by existing holders.

Counterparty
Tricor Pacific Capital Partners (Fund IV)
4:05 PM ET Form 4
Insider Selling Quicklogic Corp QUIK

Quicklogic CFO, SVP Finance Elias Nader Sells $131K of Stock

Elias Nader, CFO, SVP Finance, sold 12,152 shares of Quicklogic Corp at $10.80 a share, worth $131K in total on Sep 10, 2026. Shares held after the trade: 82,255 (-12.9%).

Value
$131K
Shares
12,152
Price
$10.80
Role
CFO, SVP Finance
Holding change
-12.9%
Trade date
Sep 10, 2026
4:04 PM ET 8-K
Shareholder Meeting Elicio Therapeutics, Inc. ELTX

Elicio Therapeutics Shareholder Meeting

Elicio Therapeutics has scheduled its 2026 Annual Meeting of Stockholders for November 12, 2026. Because the meeting date has shifted by more than 30 days from the prior year's anniversary, the company established September 24, 2026, as the new deadline for shareholder proposals and director nominations.

4:03 PM ET Form 4
Insider Selling Dexcom Inc DXCM

Dexcom EVP, Chief Financal Officer Jereme M. Sylvain Sells $303K of Stock

Jereme M. Sylvain, EVP, Chief Financal Officer, sold 3,638 shares of Dexcom Inc at $83.27 a share, worth $303K in total on Sep 10, 2026. Shares held after the trade: 146,828 (-2.4%).

Value
$303K
Shares
3,638
Price
$83.27
Role
EVP, Chief Financal Officer
Holding change
-2.4%
Trade date
Sep 10, 2026
4:03 PM ET 8-K
Investor Presentation Emergent BioSolutions Inc. EBS

Emergent BioSolutions Investor Presentation

Emergent BioSolutions CEO Joseph C. Papa is presenting at the H.C. Wainwright 28th Annual Global Investment Conference on September 14, 2026. The company filed a formal investor presentation deck as an exhibit, which outlines its strategy for combating public health threats and provides updates on its medical countermeasure portfolio, including CYFENDUS and NARCAN.

Counterparty
H.C. Wainwright
4:02 PM ET Form 4
Insider Selling Hershey Co HSY

Hershey Insider Hershey Trust Co Trustee in Trust for Milton Hershey School Sells $3.47M of Stock

Hershey Trust Co Trustee in Trust for Milton Hershey School sold 19,963 shares of Hershey Co at $173.44 to $175.50 a share (average $173.87) in 6 transactions, worth $3.47M in total between Sep 10, 2026 and Sep 11, 2026. Shares held after the trade: 816,119 (-0.0%).

Value
$3.47M
Shares
19,963
Average price
$173.87
Holding change
-0.0%
Trade date
Sep 10, 2026 to Sep 11, 2026
4:02 PM ET Form 4
Insider Selling SOPHiA Genetics SA SOPH

SOPHiA Genetics Executive Chairman Jurgi Camblong Sells $65.1K of Stock

Jurgi Camblong, Executive Chairman, sold 8,500 shares of SOPHiA Genetics SA at $7.66 a share, worth $65.1K in total on Sep 10, 2026. Shares held after the trade: 3,435,822 (-0.2%).

Value
$65.1K
Shares
8,500
Price
$7.66
Role
Executive Chairman
Holding change
-0.2%
Trade date
Sep 10, 2026
4:02 PM ET Form 4
Insider Selling SOPHiA Genetics SA SOPH

SOPHiA Genetics CLO Well Daan Van Sells $47.1K of Stock

Well Daan Van, CLO, sold 6,168 shares of SOPHiA Genetics SA at $7.63 a share, worth $47.1K in total on Sep 11, 2026. Shares held after the trade: 338,884 (-1.8%).

Value
$47.1K
Shares
6,168
Price
$7.63
Role
CLO
Holding change
-1.8%
Trade date
Sep 11, 2026
4:02 PM ET Form 4
Insider Selling Semtech Corp SMTC

Semtech EVP and CFO Mark Lin Sells $109K of Stock

Mark Lin, EVP and CFO, sold 683 shares of Semtech Corp at $159.90 a share, worth $109K in total on Sep 10, 2026. Shares held after the trade: 35,366 (-1.9%).

Value
$109K
Shares
683
Price
$159.90
Role
EVP and CFO
Holding change
-1.9%
Trade date
Sep 10, 2026
4:02 PM ET 8-K
Capital Raise Yarrow Bioscience, Inc. YARW

Yarrow Bioscience Capital Raise of $172M

Yarrow Bioscience entered into an underwriting agreement to sell 5,769,231 shares of common stock at $26.00 per share. The underwriters fully exercised their option to purchase an additional 865,384 shares, bringing the total expected net proceeds to approximately $161.8 million after expenses.

Value
$172M
Counterparty
Jefferies LLC, TD Securities (USA) LLC and Guggenheim Securities, LLC
4:01 PM ET Form 4
Insider Selling Kanzhun Ltd BZ

Kanzhun CEO Peng Jonathan Zhao Sells $6.12M of Stock

Peng Jonathan Zhao, CEO, sold 743,600 shares of Kanzhun Ltd at $8.18 to $8.28 a share (average $8.23) in 2 transactions, worth $6.12M in total between Sep 10, 2026 and Sep 11, 2026. Shares held after the trade: 2,824,080 (-11.3%).

Value
$6.12M
Shares
743,600
Average price
$8.23
Role
CEO
Holding change
-11.3%
Trade date
Sep 10, 2026 to Sep 11, 2026
4:01 PM ET 8-K
Investor Presentation Niki BioSolutions, Inc. NIKI

Niki BioSolutions Investor Presentation

Niki BioSolutions filed its corporate PowerPoint presentation which was presented by President & COO Alidad Mireskandari at the H.C. Wainwright Global Investment Conference in September 2026. The presentation highlights the company's recent all-stock merger with DiamiR Biosciences, which was completed on July 20, 2026.

Counterparty
H.C. Wainwright Global Investment Conference
4:01 PM ET 8-K
Investor Presentation Kairos Pharma, LTD. KAPA

Kairos Pharma Investor Presentation

Kairos Pharma, Ltd. issued a new investor presentation to be presented by CEO John Yu at the H.C. Wainwright 28th Annual Global Investment Conference in New York. The presentation provides an update on the company's clinical programs and activities.

Counterparty
H.C. Wainwright 28th Annual Global Investment Conference
4:01 PM ET Form 4
Insider Selling Amylyx Pharmaceuticals, Inc. AMLX

Amylyx Pharmaceuticals CFO James M. Frates Sells $350K of Stock

James M. Frates, CFO, sold 10,810 shares of Amylyx Pharmaceuticals, Inc. at $32.27 to $33.23 a share (average $32.36) in 2 transactions, worth $350K in total on Sep 10, 2026. Shares held after the trade: 233,625 (-0.4%).

Value
$350K
Shares
10,810
Average price
$32.36
Role
CFO
Holding change
-0.4%
Trade date
Sep 10, 2026
4:01 PM ET Form 4
Insider Selling Amylyx Pharmaceuticals, Inc. AMLX

Amylyx Pharmaceuticals CMO Camille L. Bedrosian Sells $325K of Stock

Camille L. Bedrosian, CMO, sold 10,028 shares of Amylyx Pharmaceuticals, Inc. at $32.21 to $33.09 a share (average $32.40) in 2 transactions, worth $325K in total on Sep 10, 2026. Shares held after the trade: 278,064 (-0.7%).

Value
$325K
Shares
10,028
Average price
$32.40
Role
CMO
Holding change
-0.7%
Trade date
Sep 10, 2026
4:01 PM ET Form 4
Insider Buying Ecovyst Inc. ECVT

Ecovyst Insider Patti A. Humble Buys $250K of Stock

Patti A. Humble bought 24,875 shares of Ecovyst Inc. at $10.05 a share, worth $250K in total on Sep 10, 2026. Shares held after the trade: 33,974 (+273.4%).

Value
$250K
Shares
24,875
Price
$10.05
Holding change
+273.4%
Trade date
Sep 10, 2026
4:01 PM ET 8-K
Clinical Trial Data Moleculin Biotech, Inc. MBRX

Moleculin Biotech Clinical Trial Data

Moleculin Biotech announced that new data on its lead drug candidate, Annamycin (naxtarubicin), will be presented at three scientific venues in September 2026, including the AACR Conference on Pancreatic Cancer. The presentations will cover the drug's organotropism, its mechanism for targeting topoisomerase II, and its ability to stimulate CD8+ T cell cytotoxicity in pancreatic tumors. These findings support the company's broader development of Annamycin beyond its lead indication in acute myeloid leukemia (AML).

Counterparty
American Association for Cancer Research (AACR)
4:00 PM ET Form 4
Insider Selling Amylyx Pharmaceuticals, Inc. AMLX

Amylyx Pharmaceuticals Co-CEO Justin B. Klee Sells $980K of Stock

Justin B. Klee, Co-CEO, sold 30,464 shares of Amylyx Pharmaceuticals, Inc. at $32.13 to $33.16 a share (average $32.18) in 2 transactions, worth $980K in total on Sep 10, 2026. Shares held after the trade: 3,613,056 (-0.0%).

Value
$980K
Shares
30,464
Average price
$32.18
Role
Co-CEO
Holding change
-0.0%
Trade date
Sep 10, 2026
4:00 PM ET Form 4
Insider Selling Amylyx Pharmaceuticals, Inc. AMLX

Amylyx Pharmaceuticals Co-CEO Joshua B. Cohen Sells $981K of Stock

Joshua B. Cohen, Co-CEO, sold 30,464 shares of Amylyx Pharmaceuticals, Inc. at $32.16 to $33.15 a share (average $32.19) in 2 transactions, worth $981K in total on Sep 10, 2026. Shares held after the trade: 3,613,123 (-0.0%).

Value
$981K
Shares
30,464
Average price
$32.19
Role
Co-CEO
Holding change
-0.0%
Trade date
Sep 10, 2026
4:00 PM ET Form 4
Insider Selling Amylyx Pharmaceuticals, Inc. AMLX

Amylyx Pharmaceuticals CLO Gina Mazzariello Sells $309K of Stock

Gina Mazzariello, CLO, sold 9,525 shares of Amylyx Pharmaceuticals, Inc. at $32.46 a share, worth $309K in total on Sep 10, 2026. Shares held after the trade: 190,849 (-4.8%).

Value
$309K
Shares
9,525
Price
$32.46
Role
CLO
Holding change
-4.8%
Trade date
Sep 10, 2026
4:00 PM ET Form 4
Insider Selling Acres Commercial Realty Corp. ACR

Acres Commercial Realty Insider David J. Bryant Sells $20K of Stock

David J. Bryant sold 1,440 shares of Acres Commercial Realty Corp. at $13.89 a share, worth $20K in total on Sep 10, 2026. Shares held after the trade: 39,875 (-3.5%).

Value
$20K
Shares
1,440
Price
$13.89
Holding change
-3.5%
Trade date
Sep 10, 2026
3:46 PM ET 8-K
Business Update QVC Group, Inc. QVCG

QVC Group Business Update

QVC Group, Inc. filed its monthly operating report with the U.S. Bankruptcy Court for the Southern District of Texas for the period ending July 31, 2026. The report discloses a cash balance of $200.6 million and a net loss for the month, as the company continues its Chapter 11 reorganization process. Although the company's plan of reorganization was confirmed in July and became effective in August, these monthly reports are required for the duration of the bankruptcy proceedings.

Term
July 2026
3:31 PM ET 8-K
M&A Deal Curaleaf Holdings, Inc. CURLF

Curaleaf Holdings Signs $11M M&A Deal with Aurora

Curaleaf Holdings has filed an application with the Alberta Securities Commission to halt Aurora's at-the-market (ATM) share issuance program during Curaleaf's pending acquisition offer. Curaleaf argues that Aurora's continued share sales at prices below the $4.00 offer price are an abusive defensive tactic that has increased the deal's cost by over $11 million and diluted shareholders by approximately 11%.

Value
$11M
Counterparty
Aurora
3:30 PM ET 8-K
Leadership Change Rainmaker Worldwide Inc. RAKR

Rainmaker Worldwide Leadership Change

Michael O’Connor resigned as Chairman, Interim CEO, and sole director of Rainmaker Worldwide Inc. effective September 10, 2026, citing health concerns. Ryan D. Moore and Michael A. Skinner were appointed to the Board of Directors to fill vacancies created by an increase in board size prior to O'Connor's departure.

3:28 PM ET Form 4
Insider Buying Omega Flex, Inc. OFLX

Omega Flex President Edwin B. Moran Buys $20.1K of Stock

Edwin B. Moran, President, bought 790 shares of Omega Flex, Inc. at $25.43 a share, worth $20.1K in total on Sep 14, 2026. Shares held after the trade: 1,790 (+79.0%).

Value
$20.1K
Shares
790
Price
$25.43
Role
President
Holding change
+79.0%
Trade date
Sep 14, 2026
3:11 PM ET 8-K
Deal Termination Rainmaker Worldwide Inc. RAKR

Rainmaker Worldwide Deal Termination with Larchwood Management Partners Inc.

Rainmaker Worldwide Inc. mutually terminated its consulting agreements with Larchwood Management Partners Inc. and 2752128 Ontario Ltd., effective April 30, 2026. The terminations are part of a management restructuring and cost-reduction effort, with the company remaining obligated for approximately $508,827 in unpaid fees and expenses plus interest. Additionally, the company confirmed the resignation of James Ross from its Board of Directors.

Counterparty
Larchwood Management Partners Inc.
3:09 PM ET Form 4
Insider Buying Omega Flex, Inc. OFLX

Omega Flex VP - CFO Matthew Francis Unger Buys $25.4K of Stock

Matthew Francis Unger, VP - CFO, bought 1,000 shares of Omega Flex, Inc. at $25.42 a share, worth $25.4K in total on Sep 14, 2026. Shares held after the trade: 1,000.

Value
$25.4K
Shares
1,000
Price
$25.42
Role
VP - CFO
Trade date
Sep 14, 2026
3:04 PM ET Form 4
Insider Selling Modine Manufacturing Co MOD

Modine Manufacturing VP, CHRO Brian Jon Agen Sells $776K of Stock

Brian Jon Agen, VP, CHRO, sold 4,306 shares of Modine Manufacturing Co at $180.30 a share, worth $776K in total on Sep 10, 2026. Shares held after the trade: 67,306 (-6.0%).

Value
$776K
Shares
4,306
Price
$180.30
Role
VP, CHRO
Holding change
-6.0%
Trade date
Sep 10, 2026
2:59 PM ET 8-K
Leadership Change Vista Credit Strategic Lending Corp.

Vista Credit Strategic Lending Leadership Change

Stephen Riddick notified the Board of Directors of his decision to resign as a director of Vista Credit Strategic Lending Corp., effective September 14, 2026. His departure includes stepping down from the Audit and Nominating and Corporate Governance Committees and was not due to any disagreement with the company.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.